ReviewJournal of diabetes science and technology2025
Diabetes Technology in Saudi Arabia: Current Status and Future Directions.
Review in Journal of diabetes science and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Technology in Diabetes: A Year in Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increasing incidence and prevalence of diabetes have led to a strain on health care systems, necessitating innovation in diabetes care delivery and substantial resource allocation for disease management and treatment of complications. Recently, Saudi Arabia has made significant strides in digital transformation, implementing cutting-edge technologies across various sectors, including the health sector.
aimsTo develop a report that examines the current status, identify challenges and opportunities in implementing diabetes technology solutions for diabetes management, and provide a strategic roadmap for enhancing the accessibility to diabetes technology solutions.
methodsThe Saudi National Diabetes Center (SNDC) convened a group of experts to develop a comprehensive report that serves a dual purpose. First, it provides a narrative review on insulin pumps and CGMs that are approved by the SFDA and discusses their clinical effectiveness based on local studies. Second, it presents a comprehensive report on the current status and future directions of diabetes technology in Saudi Arabia.
resultsOur experts identified six major barriers to the adoption of diabetes technology solutions in Saudi Arabia and proposed 14 strategic initiatives that can help overcome these barriers and transform the current overwhelmed diabetes care model into a more innovative, effective, efficient, safe, accessible, and cost-effective model of care.
conclusionWhile Saudi Arabia offers one of the most diverse ranges of diabetes technology solutions globally, major accessibility barriers persist. The SNDC Diabetes Technology Report is the first report developed primarily for policymakers, regulatory bodies, clinicians, academicians, and industry partners to address these accessibility barriers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.